HYLIGHT is an R&D&I project that has received around 2 million euros in funding for the second phase of ATTRACT and aims to develop a diagnostic device to select embryos based on their metabolic profiles and increase the success rates of in vitro fertilization techniques.
The idea of the project is to help solve a problem affecting one out of seven couples in Europe who experience infertility problems and turn to in vitro fertilization techniques to overcome these difficulties and become parents.
This project, coordinated by the Institute for Bioengineering of Catalonia (IBEC), stands for “Prototyping a light-sheet microscope for the diagnostic of embryo implantation based on hyperspectral phasor analysis”, and it’s a follow-up of the HYSPLANT project granted at ATTRACT phase 1, which developed a proof-of-concept device to select embryos based on their metabolic profiles.
More information about the HYLIGHT project here.
Read the full story at the IBEC website here.
